A 10748: Provides for coverage for treatments to slow the progression of Alzheimer's disease and related dementias.
The bill aims to improve coverage for treatments to slow the progression of Alzheimer's disease and related dementias in New York State. It requires health insurance policies to cover medically necessary diagnostic testing and FDA-approved treatments or medications prescribed to slow the progression of Alzheimer's disease and other dementias, without subjecting them to step therapy. The bill also applies to group and blanket policies, as well as medical expense indemnity corporations, hospitals, and health service corporations. Coverage will be provided in accordance with the FDA label, as determined by a licensed physician. The changes will take effect on January 1st of the following year, and will apply to all policies and contracts issued, renewed, modified, altered or amended after that date.
- What is the current status of A 10748?
- As of June 30, 2026, A 10748 is recorded as "Introduced": it has been introduced and is waiting for its first committee hearing or floor vote. The last recorded action, on March 27, 2026, was "referred to insurance".
- Did A 10748 pass?
- Not yet. A 10748 has been introduced and has not passed either house.
- Who wrote A 10748, and where is it now?
- A 10748 was authored by Asm. Angelo Santabarbara with 6 coauthors. Its committee of record is Assembly Insurance. It is filed under ISC, alongside 202 other New York ISC bills this session.
| Mar. 27, 2026 | referred to insurance |
STATE OF NEW YORK ________________________________________________________________________ 10748 IN ASSEMBLY March 27, 2026 ___________ Introduced by M. of A. SANTABARBARA -- read once and referred to the Committee on Insurance AN ACT to amend the insurance law and the social services law, in relation to coverage for treatments to slow the progression of Alzheimer's disease and related dementias The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Subsection (i) of section 3216 of the insurance law is 2 amended by adding a new paragraph 11-d to read as follows: 3 (11-d) Every policy which provides medical, major medical, or similar 4 comprehensive-type coverage shall provide coverage for all medically 5 necessary diagnostic testing and United States food and drug administra- 6 tion-approved treatments or medications prescribed to slow the progres- 7 sion of Alzheimer's disease and other dementia, in accordance with the 8 United States food and drug administration label, as determined by a 9 physician licensed to practice medicine in all its branches. Coverage of 10 United States food and drug administration-approved treatments or medi- 11 cations prescribed to slow the progression of Alzheimer's disease or 12 another related dementia pursuant to this paragraph shall not be subject 13 to step therapy. 14 § 2. Subsection (l) of section 3221 of the insurance law is amended by 15 adding a new paragraph 11-d to read as follows: 16 (11-d) Every insurer delivering a group or blanket policy or issuing a 17 group or blanket policy for delivery in this state that provides cover- 18 age for medical, major medical, or similar comprehensive-type coverage 19 shall provide coverage for all medically necessary diagnostic testing 20 and United States food and drug administration-approved treatments or 21 medications prescribed to slow the progression of Alzheimer's disease 22 and other dementia, in accordance with the United States food and drug 23 administration label, as determined by a physician licensed to practice 24 medicine in all its branches. Coverage of United States food and drug 25 administration-approved treatments or medications prescribed to slow the 26 progression of Alzheimer's disease or another related dementia pursuant 27 to this paragraph shall not be subject to step therapy. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD15298-01-6A. 10748 2 1 § 3. Section 4303 of the insurance law is amended by adding a new 2 subsection (p-2) to read as follows: 3 (p-2) A medical expense indemnity corporation, a hospital service 4 corporation or a health service corporation that provides coverage for 5 medical, major medical, or similar comprehensive-type coverage shall 6 provide coverage for all medically necessary diagnostic testing and 7 United States food and drug administration-approved treatments or medi- 8 cations prescribed to slow the progression of Alzheimer's disease and 9 other dementia, in accordance with the United States food and drug 10 administration label, as determined by a physician licensed to practice 11 medicine in all its branches. Coverage of United States food and drug 12 administration-approved treatments or medications prescribed to slow the 13 progression of Alzheimer's disease or another related dementia pursuant 14 to this subsection shall not be subject to step therapy. 15 § 4. Subdivision 2 of section 365-a of the social services law is 16 amended by adding a new paragraph (mm-1) to read as follows: 17 (mm-1) all medically necessary diagnostic testing and United States 18 food and drug administration-approved treatments or medications 19 prescribed to slow the progression of Alzheimer's disease and other 20 dementia, in accordance with the United States food and drug adminis- 21 tration label, as determined by a physician licensed to practice medi- 22 cine in all its branches. Coverage of United States food and drug admin- 23 istration-approved treatments or medications prescribed to slow the 24 progression of Alzheimer's disease or another related dementia pursuant 25 to this paragraph shall not be subject to step therapy. 26 § 5. This act shall take effect on the first of January next succeed- 27 ing the date on which it shall have become a law and shall apply to all 28 policies and contracts issued, renewed, modified, altered or amended on 29 or after such date.